MedPath

TOKYO MEDICAL AND DENTAL UNIVERSITY

TOKYO MEDICAL AND DENTAL UNIVERSITY logo
🇯🇵Japan
Ownership
-
Established
1946-01-01
Employees
-
Market Cap
-
Website
https://www.tmd.ac.jp/

Clinical Trials

442

Active:1
Completed:203

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:10
Phase 2:5
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (441 trials with phase data)• Click on a phase to view related trials

Not Applicable
419 (95.0%)
Phase 1
10 (2.3%)
Phase 2
5 (1.1%)
Phase 4
4 (0.9%)
Phase 3
2 (0.5%)
Early Phase 1
1 (0.2%)

Metastasis-directed Therapy for Oligometastases of Breast Cancer

Phase 3
Recruiting
Conditions
Oligometastasis
Metastatic Breast Cancer
Breast Cancer
Interventions
Drug: Systemic therapy for 12 weeks after primary registration
Procedure: Radiation therapy (SBRT/conventional RT)
Procedure: Surgery
First Posted Date
2023-11-18
Last Posted Date
2025-04-11
Lead Sponsor
Tokyo Medical and Dental University
Target Recruit Count
340
Registration Number
NCT06135714
Locations
🇯🇵

Tokyo Medical and Dental Univetsity, Tokyo, Japan

Three Different Oral Hygiene Regimes on Three Volatile Sulfur Compounds

Phase 4
Completed
Conditions
Halitosis
First Posted Date
2016-02-23
Last Posted Date
2016-02-23
Lead Sponsor
Tokyo Medical and Dental University
Target Recruit Count
30
Registration Number
NCT02689297

Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease

Phase 3
Active, not recruiting
Conditions
Crohn Disease
Interventions
First Posted Date
2015-01-06
Last Posted Date
2023-11-27
Lead Sponsor
Tokyo Medical and Dental University
Target Recruit Count
100
Registration Number
NCT02332356
Locations
🇯🇵

Gastroenterology and Hepatology, Tokyo Medical and Dental UNIV, Tokyo, Japan

Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery

Phase 4
Withdrawn
Conditions
Hepatocellular Carcinoma
Hepatoma
Cholangiocarcinoma
Gallbladder Neoplasms
Interventions
First Posted Date
2014-06-25
Last Posted Date
2023-05-03
Lead Sponsor
Tokyo Medical and Dental University
Registration Number
NCT02174575
Locations
🇯🇵

Tokyo Medical and Dental University, Tokyo, Japan

Effects of a Chewing Gum Containing POs-Ca and Fluoride on Enamel

Early Phase 1
Completed
Conditions
Enamel Subsurface Lesion
First Posted Date
2011-06-21
Last Posted Date
2011-06-21
Lead Sponsor
Tokyo Medical and Dental University
Target Recruit Count
36
Registration Number
NCT01377493
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.